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Alterations in ocular pathogen susceptibility to gentamicin
and tobramycin
Purpose: To evaluate and compare the “in vitro” susceptibility of
ocular bacterial isolates to aminoglycoside antibiotics (gentamicin and
tobramycin) and to analyze the alteration in susceptibility after 14
years of introduction of tobramycin in Brazilian ophthalmic practice.
Methods: The results of antibiotic susceptibility tests in a period of
three years with 887 bacterial strains (Study “A”) were retrospectively
analyzed and then compared with the results obtained fourteen years
ago with 124 microorganisms (Study “B”), when tobramycin was
first tested in Brazil for isolated eye strains. In both studies, the data
analyzed were from the files of the Ocular Microbiology Laboratory
of the Federal University of São Paulo.
Results: The “in vitro” effectiveness of both antibiotics regarding the
total number of positive isolates was significantly higher for tobramycin
in both studies. An increase in the Staphylococcus aureus strains resistant
to tobramycin and only a decreasing trend in the number of microor-
ganisms resistant to gentamicin was observed. With Pseudomonas sp, a
strong tendency to the increase of susceptibility to gentamicin and to the
appearance of strains resistant to tobramycin occurred.
Conclusions: The introduction of tobramycin in the treatment of
ocular infections and the possible decrease in number of gentamicin
prescriptions during the last fourteen years might be the cause of
modifications in the susceptibility observed in the total of positive
isolates mainly Staphylococcus aureus and Pseudomonas sp. For the
isolated microorganisms from the conjunctiva, the sensitivity to both
antibiotics was equivalent.
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SUMMARY
INTRODUCTION
The most frequent infections of the cornea and conjunctiva, which are
submitted to a laboratory evaluation in our environment, are due to
bacteria, and an initial treatment with broad spectrum antibiotics is usually
recommended after the clinical diagnosis and after scraping the site of
infection 1, 2. In most situations, mainly for corneal infections, the initial
treatment starts before the confirmation of culture results. Conjunctival
cultures are not always necessary and recommended.
Susceptibility tests to microorganisms isolated from ocular infections
are recommended since the results are useful not only in specific cases but
also as epidemiological data 2, 3.
Keywords: Ocular Infections; Antibiotic susceptibility; Gentamicin and Tobramycin.
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Gentamicin and tobramycin, of well-known use in
ophthalmology, belong to the aminoglycoside group together
with streptomycin and neomycin 4-7. Their mechanism of
action is by means of binding to the bacterial ribosome,
inhibiting protein synthesis. In general they are bacteriostatic,
but in higher doses, they may have bactericidal property 7. The
spectrum of the aminoglycoside action includes both Gram
negative and Gram positive microorganisms 2, 4, 5, 6, 8.
Gentamicin and tobramycin, as eye drops, are stable
solutions. The commercially available concentration is 3 mg/
ml which is the ideal concentration recommended for the
treatment of eyelid and conjunctiva infections 5, 8.
The results of the “in vitro” antimicrobial susceptibility
tests by the time of tobramycin introduction for the treatment
of eye infections, showed a greater efficacy of tobramycin
regarding all microorganisms isolated from ocular infections,
specially Pseudomonas sp and Staphylococcus aureus, when
compared with the results of gentamicin susceptibility 5, 6, 9, 10.
The purpose of this study is to evaluate and compare the
“in vitro” susceptibility to gentamicin and tobramycin to ocu-
lar microorganisms of the conjunctiva, cornea and intraocular
fluids, isolated by the Ocular Microbiology Laboratory of the
Federal University of São Paulo (UNIFESP-EPM) and also to
evaluate alterations in the susceptibility occurred by the
analysis of a previous study carried out fourteen years ago in
the same institution.
MATERIAL AND METHODS
The Ocular Microbiology Laboratory of UNIFESP - EPM
receives material for cultures and microbiological evaluation
from patients treated at the São Paulo Hospital and also in the
community.
The samples for microbiological evaluation are collected
directly from the infected area in all cases of lid, conjunctival
and corneal infections. In the case of intraocular infection,
paracentesis is performed in the anterior and vitreous chamber.
Cotton swabs soaked in Brain-Heart-Infusion (BHI)
solution are used for collection of samples for cultures from
the conjunctiva. Corneal samples were obtained using a
Kimura platinum spatula and those of the aqueous and
vitreous humor through direct puncture of the anterior
chamber. The aqueous samples were also obtained by
filtration of diluted Balanced Salt Solution (BSS) material
collected during vitrectomy performed for infected cases.
All samples were cultured in chocolate agar, blood agar
and Sabouraud dextrose agar 3, 11. From each sample, smears
stained by the Gram and Giemsa methods were obtained for
bacterioscopy and cytology respectively.
Cultures were considered positive when presenting a
significant growth of at least two seeded samples in one or
more plates.
The isolated microorganisms were submitted to antibiotic
susceptibility tests using the disk diffusion method 2, 6 with an
observed concentration in the disc of 10 µg for both antibiotics 2.
The reading was performed by measuring the diameter of the
inhibiting zone around the disk 2, in agreement with the National
Committee for Clinical Laboratory Standards (NCCLS) criteria
for both antibiotics: resistant (≤ 12 mm); intermediate (13-14
mm) and susceptible (≥ 15 mm) 1-3.
The results of laboratory tests of cases referred to the
Ocular Microbiology Laboratory of UNIFESP - EPM were
retrospectively analyzed during the period from June 1995 to
May 1998 (Study “A”) and then compared with the results
obtained from May 1983 to January 1985 (Study “B”).
Of the 2,293 cases of Study “A”, 1,840 cultures were
carried out, with positive results in 827 cases. Isolation of only
one organism was observed in 792 cases while 95 presented
growth of more than one microorganism. Therefore, this study
consisted of 887 bacteria that were submitted to antibiotic
susceptibility tests.
In Study “B”, of 112 cultures, 124 microorganisms were
isolated. Only microorganisms with a more significant
positive growth were used for comparison of results regarding
the alteration in susceptibility between the two analyses.
In order to simplify analysis of the results of these studies,
strains were grouped as follows: Staphylococcus aureus (S.
aureus); coagulase-negative Staphylococcus (CNS); other
Gram positive cocci (CGP) such as Streptococcus pneumo-
niae, non-hemolytic Streptococcus, Streptococcus viridians
and Streptococcus pyogenes; Moraxella sp (Morax); Pseudo-
monas sp (Pseudo); other Gram negative microorganisms
(Gram Neg) such as Proteus mirabilis, Proteus vulgaris,
Proteus sp, Serratia sp, Citrobacter sp, Enterobacter sp,
Klebsiella sp, Hafnia alvei, Listeria sp, Neisseria sp, Provi-
dencia sp, E. coli and Morganella morganii; Haemophilus sp
(Haem) and Gram positive microorganisms (Gram Pos) such
as Bacillus sp and C. xerosis.
In the two studies, analysis and comparison of ocular
pathogen susceptibility to both antibiotics were performed in
relation to the total isolated microorganisms and to each group
of microorganisms apart from the site of collection. Then, in
Study “A”, susceptibility to each group of microorganisms
regarding the site of the collection was also analyzed and
compared. In Study “B”, due to the small sample of each site
of collection, no analysis or comparisons of the susceptibility
to both antibiotics were performed.
In both studies, statistical analysis using the chi-square test
was used for one sample, assuming that the theoretical
distribution of the number of sensitive cases was equitably
distributed among the different sites of collection 12, 13. In
order to verify the differences between the proportion of mi-
croorganisms susceptible to gentamicin and tobramycin, a test
for two proportions, whose populations were not independent,
was used as proposed by Mc Nemar. The statistics calculated
was defined as Uo2 (12). Level of significance was 0.05 (5%).
Significant Uo2 statistics is marked by an asterisk (*) 12 (p ≤
0.05). N.S. means a nonsignificant statistics (p ≥ 0.05) 13.
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When comparing the present results of susceptibility with
those obtained fourteen years ago, the test for two indepen-
dent proportions was used when the sample was significant
and the statistics were then defined as z 14. When the sample
was smaller, as in the case of Pseudomonas sp found in Study
“B”, the Fisher’s test was used 13. For both tests, the level of
significance was 0.05 (5%). The above mentioned parameters
of significance were used 12, 13.
RESULTS
Of the 887 bacteria isolated in Study “A”, 484 were from
the conjunctiva, 324 from the cornea, 36 from aqueous and/or
vitreous humor and 43 from varied areas such as limbus and
contact lenses. Of the 124 positive isolates found in Study
“B”, 44 were from the conjunctiva, 22 from the cornea, 1 from
aqueous and/or vitreous humor, 40 from lids and 18 from the
lacrimal sac.
Regarding the frequency of microorganisms in Study “A”,
365 CNS were identified which is comparable to 41.2% of the
total, while S. aureus was the second most frequent microor-
ganism with 222 positive isolates (25.0%). Concerning Gram
negative microorganisms, Pseudomonas sp was the most
frequently isolated with 5.9% (Table 1). Data from Study “B”
emphasize the high frequency of S. aureus (83.1%) while the
Table 1. Antibiotic susceptibility of different isolated groups of ocular microorganisms to gentamicin and
tobramycyn (Study “A”) 1999 – São Paulo - Brazil
Antibiotics Calculated Statistics
Bacteria N Gentamicin Tobramycin Uo2
Susceptible Susceptible
N % N % X crit2 > 3,84
CNS 365 305 83.6 303 83.0 0,096 N.S.
S. aureus 222 169 76.1 187 84.2 7,349 (*)
CGP 117 48 41.0 54 46.2 1,631 N.S.
Gram Neg 63 59 93.7 57 90.5 0 N.S.
Pseudo 53 44 83.0 46 86.8 0,998 N.S.
Morax 40 38 95.0 37 92.5 1 N.S.
Haem 18 15 83.3 16 88.9 1 N.S.
Gram Pos 9 9 100 9 100 T.E.
TOTAL 887 687 77.5 709 79.9 4,249 (*)
Uo2: Statistical Test; T.E: Test exemption; N.S.: Not significant; (*): Significant
CNS – coagulase-negative Staphylococcus; S. aureus - Staphylococcus aureus;  CGP - other Gram Positive Cocci (Streptococcus pneumoniae, non-hemolytic
Streptococcus, Streptococcus viridans and Streptococcus pyogenes); Gram Neg - Gram negative microorganisms (Proteus mirabilis, Proteus vulgaris, Proteus sp,
Serratia sp, Citrobacter sp, Enterobacter sp, Klebsiella sp, Hafnia alvei, Listeria sp, Neisseria sp, Providencia sp, E. coli, Pseudomonas aeruginosa, Pseudomonas
fluorescens and Morganella morganii); Pseudo - Pseudomonas sp; Morax - Moraxella sp; Haem - Haemophilus sp; Gram Pos - Gram positive microorganisms (Bacillus
sp and C. xerosis).
Table 2. Antibiotic susceptibility of different isolated groups of ocular microorganisms to gentamicin and
tobramycyn (Study “B”) 1985 – São Paulo - Brazil
Antibiotics Calculated Statistics
Bacteria N Gentamicin Tobramycin Uo2
Susceptible Susceptible
N % N % X crit2 > 3,84
S. aureus 103 77 74.8 95 92.2 9.523 (*)
Pseudo 7 4 57.1 7 100 3.054 N.S.
Gram Neg 7 5 71.4 6 85.7 0.996 N.S.
CNS 2 2 100 2 100 T.E.
Morax 2 2 100 1 50.0 1 N.S.
CGP 1 1 100 1 100 T.E.
Haem 1 0 0 1 100 0 N.S.
Gram Pos 1 1 100 1 100 T.E.
TOTAL 124 92 74.2 114 91.9 12.114 (*)
Uo2: Statistical Test; T.E: Test exemption; N.S.: Not significant; (*): Significant
S. aureus - Staphylococcus aureus; Pseudo - Pseudomonas sp; Gram Neg - Gram negative microorganisms (Proteus mirabilis, Enterobacter sp and E. coli); SCN –
coagulase-negative Staphylococcus; Morax - Moraxella sp; CGP - other Gram Positive Cocci (Streptococcus pneumoniae); Haem - Haemophilus sp; Gram Pos - Gram
positive microorganisms (C. xerosis).
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most frequent microorganism was Pseudomonas sp (5.6%)
with only 7 strains (Table 2). Since this study is related to
antibiotic susceptibility tests, there is an explanation for the
difference in frequency of CNS between the two studies.
When Study “B” was performed, the CNS isolated at the
Laboratory was not submitted to susceptibility tests.
The analysis of the susceptibility results of the total
microorganisms isolated in both studies shows a difference
between the microbial susceptibility of both antibiotics
tobramycin being a more efficacious antibiotic mainly against
S. aureus (Table 1, 2 and 5).
In Study “A”, with a large number of isolates from each
site of infection (conjunctiva, cornea and intraocular fluids),
we could compare the antibiotic susceptibility results of each
group of microorganisms at all sites of infection. With this
evaluation, we could show that tobramycin was more effective
“in vitro” than gentamicin against S. aureus isolated from
corneal infections (Table 3). The difference observed
regarding Staphylococcus aureus interferes with the analysis
of susceptibility of the total of these microorganisms, when we
analyzed all sites of collection (Table 1).
The results of Pseudomonas sp susceptibility to tobramy-
cin and gentamicin were respectively, 86.8% and 83.0% in
Study “A” and 100% and 57.1% in Study “B”, without a
statistically significant difference of effectiveness between
both antibiotics. (Tables 1, 2).
The comparison of the present susceptibility results with
those obtained 14 years ago showed an inferior susceptibility to
tobramycin in relation to the total analyzed bacteria (Table 5).
An increase in the Staphylococcus aureus strains resistant to
tobramycin was observed and only a trend towards a decrease in
the number of strains of this microorganism resistant to
gentamicin (Tables 4, 5).
Regarding Pseudomonas sp, there is a strong tendency to
increase in the susceptibility to gentamicin and the appearance
of strains resistant to tobramycin (Tables 4, 5).
CNS isolates in Study “B” were in small number, not
allowing comparison of the results between the studies.
CONCLUSIONS
“In vitro” susceptibilities of isolated ocular microorganisms
not always translate the reality of “in vivo” action of some specific
drugs, but they are strong epidemiological indicatives 2, 15.
Similar to other previous evaluations, a great number of
cultures carried out in this study did not present growth of
microorganisms. There are several explanations for this fact
like the presence of viral infections, use of topical antibiotics
before cultures were performed, insufficient material, the
presence of microorganisms that do not grow in regular media
such as anaerobic bacteria and Mycobacteria 11, 16.
Gram positive cocci are the most frequent bacteria isolated
from conjuntival, corneal and intraocular infection in several
series and also the most frequent isolated from conjunctival
normal flora 1, 2, 11, 10, 17.
The microorganisms isolated from the eyes are more sus-
ceptible to tobramycin than to gentamicin but the difference
between the susceptibilities of these two antibiotics is smaller
in the recent study (Tables 1, 2).
In order to look for the greatest susceptibility difference in
the data obtained from Study “A”, we analyzed the several
sites of collection and the different groups of microorganisms,
finding that the Staphylococcus aureus strains isolated in
cases of corneal ulcer were significantly more susceptible to
tobramycin than to gentamicin (Table 3). This datum has been
Table 3. Antibiotic susceptibility of microorganismis isolated from the cornea to gentamicin and
tobramycyn (Study “A”) 1999 – São Paulo - Brazil
Antibiotics Calculated Statistics
Bacteria N Gentamicin Tobramycin Uo2
Susceptible Susceptible
N % N % X crit2 > 3,84
CNS 76 62 81.6 58 76.3 1.142 N.S.
S. aureus 68 49 72.1 60 88.2 7.121 (*)
CGP 74 28 37.8 34 45.9 2.571 N.S.
Gram Neg 25 24 96.0 24 96.0 T.E.
Pseudo 46 39 84.8 40 87.0 0.335 N.S.
Morax 32 30 93.8 29 90.6 0.998 N.S.
Haem 2 2 100 2 100 T.E.
Gram Pos 1 1 100 1 100 T.E.
TOTAL 324 235 72.5 248 76.5 0.184 N.S.
Uo2: Statistical Test; T.E: Test exemption; N.S.: Not significant; (*): Significant
CNS – coagulase-negative Staphylococcus; S. aureus - Staphylococcus aureus;  CGP - other Gram Positive Cocci (Streptococcus pneumoniae, non-
hemolytic Streptococcus, Streptococcus viridans and Streptococcus pyogenes); Gram Neg - Gram negative microorganisms (Proteus mirabilis,
Proteus vulgaris, Proteus sp, Serratia sp, Citrobacter sp, Enterobacter sp, Klebsiella sp, E. coli, Pseudomonas aeruginosa, Pseudomonas fluorescens
and Morganella morganii); Pseudo- Pseudomonas sp; Morax - Moraxella sp; Haem - Haemophilus sp; Gram Pos - Gram positive microorganisms
(Bacillus sp and C. xerosis).
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observed constantly in the evaluations performed in the same
laboratory when the susceptibility of isolated strains of the
cornea is compared with that of isolated strains of the
conjunctiva, the microorganisms isolated from the cornea
being more resistant than the isolates from the conjunctiva.
Regarding the option for treatment of Pseudomonas sp
infections, tobramycin prescription is still preferable to genta-
micin since these bacteria present levels of susceptibility over
86%, considering that the most important action spectrum of
the aminoglycoside antibiotics is on Gram negative bacteria.
The comparison of the results of both studies, one perfor-
med at the time when tobramycin was first tested for topic use
in Brazil (Study “B”) and the other at present (Study “A”), has
demonstrated that the susceptibility of ocular isolates to ami-
noglycoside antibiotics has changed in the last years (Tables
4, 5) since increase in bacterial resistance to tobramycin has
been noted. This alteration can be analyzed for S. aureus
groups and, possibly, for Pseudomonas sp, the susceptibilities
in Study “A” being 84.2% and 86.8%, respectively, and in
Study “B” 16, 17 92.2% and 100%, respectively. The number of
positive isolates of other microorganisms found in Study “B”
was not significant, not allowing analysis and comparison in the
present study. The difference in frequency of CNS submitted to
antibiotic susceptibility tests observed in the two studies is due
Table 4. Comparison of antibiotic susceptibility of different isolated groups of ocular microorganisms
to gentamicin – São Paulo - Brazil
Antibiotics Calculated Statistics
Bacteria Gentamicin p ≤ 0.05
Study “A” Study “B”
N % N %
CNS 305 83.6 2 100 n.c.
S. aureus 169 76.1 77 74.8 0.8026 N.S.
CGP 48 41.0 1 100 n.c.
Gram Neg 59 93.7 5 71.4 n.c.
Pseudo 44 83.0 4 57.1 0.1108 N.S.
Morax 38 95.0 2 100 n.c.
Haem 15 83.3 0 0 n.c.
Gram Pos 9 100 1 100 n.c.
TOTAL 687 77.5 92 74.2 0.3954 N.S.
p = Statistical Test; n.c.= Not calculated (sample not representative); N.S.= Not significant
CNS – coagulase-negative Staphylococcus; S. aureus - Staphylococcus aureus; CGP - other Gram Positive Cocci (Streptococcus pneumoniae, non-
hemolytic Streptococcus, Streptococcus viridans and Streptococcus pyogenes); Gram Neg - Gram negative microorganisms (Proteus mirabilis,
Proteus vulgaris, Proteus sp, Serratia sp, Citrobacter sp, Enterobacter sp, Klebsiella sp, Hafnia alvei, Listeria sp, Neisseria sp, Providencia sp, E. coli,
Pseudomonas aeruginosa, Pseudomonas fluorescens and Morganella morganii); Pseudo Pseudomonas sp; Morax - Moraxella sp; Haem - Haemophilus
sp; Gram Pos - Gram positive microorganisms (Bacillus sp and C. xerosis).
Table 5. Comparison of antibiotic susceptibility of different isolated groups of ocular microorganisms
to tobramycin – São Paulo - Brazil
Antibiotics Calculated Statistics
Bacteria Tobramycin p ≤ 0.05
Study “A” Study “B”
N % N %
CNS 303 83.0 2 100 n.c.
S. aureus 187 84.2 95 92.2 0.0478 (*)
CGP 54 46.2 1 100 n.c.
Gram Neg 57 90.5 6 85.7 n.c.
Pseudo 46 86.8 7 100 0.3990 N.S.
Morax 37 92.5 1 50.0 n.c.
Haem 16 88.9 1 100 n.c.
Gram Pos 9 100 1 100 n.c.
TOTAL 709 79.9 114 91.9 0.0012 (*)
p = Statistical Test; n.c.= Not calculated (sample not representative); N.S.= Not significant; (*): Significant
CNS – coagulase-negative Staphylococcus; S. aureus - Staphylococcus aureus; CGP - other Gram Positive Cocci (Streptococcus pneumoniae, non-
hemolytic Streptococcus, Streptococcus viridans and Streptococcus pyogenes); Gram Neg - Gram negative microorganisms (Proteus mirabilis, Proteus
vulgaris, Proteus sp, Serratia sp, Citrobacter sp, Enterobacter sp, Klebsiella sp, Hafnia alvei, Listeria sp, Neisseria sp, Providencia sp, E. coli,
Pseudomonas aeruginosa, Pseudomonas fluorescens and Morganella morganii); Pseudo Pseudomonas sp; Morax - Moraxella sp; Haem - Haemophilus
sp; Gram Pos - Gram positive microorganisms (Bacillus sp and C. xerosis).
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to the orientation given by the time of Study “B” when the
collections from the conjunctiva with positive CNS growth
were not submitted to susceptibility tests for several antibiotics.
Regarding microorganism susceptibility to gentamicin,
the alteration found during these years was a trend towards an
increase in susceptibility not only in relation to total positive
isolates but also for Pseudomonas sp and S. aureus groups.
Even after 14 years of using tobramycin in the treatment of
ocular infections, the isolated ocular bacteria present a greater
susceptibility to tobramycin as compared with the number of
microorganisms susceptible to gentamicin.
In spite of infections of the conjunctiva being in general the
most frequent ocular infections, corresponding to a great
number of positive isolates, not all cases will be submitted to
laboratory evaluation. We believe that several positive bacteria
isolated from the conjunctiva correspond to the normal flora.
Although the results of “in vitro” microorganism suscep-
tibility do not guarantee the equivalent clinical response, the
microbial susceptibility to the two antibiotics presents levels
that indicate the possibility of prescribing these drugs 1, 3,
mainly in relation to infectious caused by Gram negative
organisms and, at a second level, for CNS and S. aureus.
This alteration of susceptibility of microorganisms demons-
trated in these studies, mainly that of S. aureus to both antibiotics,
is possibly due to the preference for prescribing tobramycin,
most likely inducing the formation of resistant strains.
Other broad spectrum antibiotics are available for topical
use, such as fluoroquinolones, that more recently were
introduced for ophthalmic use and have shown to be a good
choice for the treatment of several ocular infections.
The aminoglycosides gentamicin and tobramycin are
stable antibiotics with good penetration in the cornea, when
used in the correct doses, and do not present deposits when
concomitantly used with contact lenses. They can be used for
the treatment of corneal infections but the available concen-
tration of antibiotics has to be adequately increased. This is
also one of the great differences between aminoglycosides and
fluoroquinolones, whose available commercial concentration
for the treatment of conjunctival infection is adequate also for
the treatment of corneal infection.
RESUMO
Objetivos: Avaliar e comparar a sensibilidade “in vitro” de
bactérias isoladas do olho humano aos aminoglicosídeos
gentamicina e tobramicina, e analisar a mudança de sensi-
bilidade ocorrida após quatorze anos de uso.
Métodos: Os resultados dos antibiogramas realizados no
período de três anos com 887 bactérias (Estudo “A”) foram
comparados com os resultados obtidos há 14 anos com 124
microrganismos (Estudo “B”), quando tobramicina foi pela
primeira vez testada no Brasil para cepas isoladas do olho.
Resultados: A eficácia “in vitro” de ambos os antibióticos
em relação ao total dos isolamentos positivos foi significan-
temente mais alta para a tobramicina em ambos os estudos.
A comparação dos resultados atuais de sensibilidade com
aqueles obtidos há 14 anos demonstra uma menor sensibili-
dade à tobramicina com relação ao total de bactérias
analisadas. Observou-se também um aumento de cepas de
Staphylococcus aureus resistentes à tobramicina e apenas
uma tendência à diminuição do número de cepas deste
microrganismo resistentes à gentamicina. Com relação à
Pseudomonas sp, existe uma forte tendência ao aumento de
sensibilidade à gentamicina e o aparecimento de cepas
resistentes à tobramicina.
Discussão: A introdução da tobramicina no tratamento de
infecções oculares e uma provável diminuição do número de
prescrições de gentamicina durante estes 14 anos podem ser a
causa das modificações da sensibilidade observada do total
de isolamentos positivos, principalmente de Staphylococcus
aureus e Pseudomonas sp. Para os microrganismos isolados
da conjuntiva, o espectro de ação dos dois antibióticos é
equivalente.
Palavras-chave: Infecções oculares; Sensibilidade “in vitro”;
Gentamicina; Tobramicina.
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